Stephen V Faraone Selected Research

Amphetamine (Amfetamine)

5/2021	How Frequent Is Switching From an Initial Stimulant Family to the Alternative One in the Clinical Setting?: A Pilot Study of 49 Consecutively Referred Medication-Naive Adults With Attention-Deficit/Hyperactivity Disorder.
1/2021	A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity Disorder.
1/2018	The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
1/2017	Pharmacokinetic and Pharmacodynamic Properties of Lisdexamfetamine in Adults with Attention-Deficit/Hyperactivity Disorder.
2/2015	Toward quality care in ADHD: defining the goals of treatment.
9/2013	Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies.
9/2011	Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study.
4/2010	Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder.
9/2008	Effect of stimulants on height and weight: a review of the literature.
9/2007	Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen V Faraone Research Topics

Disease

220	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2022 - 01/2002
34	Schizophrenia (Dementia Praecox) 01/2022 - 02/2002
15	Substance-Related Disorders (Drug Abuse) 01/2016 - 01/2003
15	Bipolar Disorder (Manic Depressive Psychosis) 02/2015 - 07/2002
11	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 05/2004
9	Mania (Manias) 01/2022 - 05/2006
6	Antisocial Personality Disorder (Antisocial Personality) 01/2020 - 02/2006
5	Mood Disorders (Mood Disorder) 01/2022 - 01/2004
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 09/2012
4	Neurodevelopmental Disorders 01/2022 - 01/2016
4	Mental Disorders (Mental Disorder) 01/2021 - 06/2004
4	Alcoholism (Alcohol Abuse) 12/2019 - 01/2003
4	Conduct Disorder (Conduct Disorders) 01/2019 - 02/2009
4	Autistic Disorder (Autism) 03/2017 - 01/2012
4	Anxiety Disorders (Anxiety Disorder) 02/2015 - 02/2006
4	Tics (Tic) 02/2006 - 01/2002
3	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 10/2007
3	Autism Spectrum Disorder 01/2020 - 06/2016
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2019 - 07/2012
3	Tobacco Use Disorder (Nicotine Dependence) 01/2016 - 02/2006
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2014 - 03/2006
2	Sleep Wake Disorders 01/2021 - 01/2019
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 01/2019
2	Epilepsy (Aura) 01/2021 - 07/2010
2	Oppositional Defiant Disorder 01/2019 - 02/2009
2	Hypersensitivity (Allergy) 01/2018 - 12/2014
2	Panic Disorder (Panic Attack) 12/2014 - 06/2005
2	Genetic Predisposition to Disease (Genetic Predisposition) 08/2014 - 03/2013
2	Overweight 10/2013 - 09/2008
2	Motor Skills Disorders (Motor Skills Disorder) 10/2013 - 03/2012
2	Psychotic Affective Disorders 03/2013 - 01/2004

Drug/Important Bio-Agent (IBA)

38	Methylphenidate (Ritalin)FDA LinkGeneric 03/2022 - 06/2002
28	Pharmaceutical PreparationsIBA 01/2021 - 04/2002
25	Biological ProductsIBA 01/2022 - 06/2003
19	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2002
17	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017 - 07/2004
13	Amphetamine (Amfetamine)FDA LinkGeneric 05/2021 - 04/2005
13	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 06/2016 - 01/2002
13	Serotonin (5 Hydroxytryptamine)IBA 01/2016 - 01/2004
12	Lisdexamfetamine Dimesylate FDA Link 01/2021 - 06/2008
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2004
9	Biomarkers (Surrogate Marker)IBA 10/2021 - 07/2012
9	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2017 - 02/2005
8	Dopamine Receptors (Dopamine Receptor)IBA 01/2017 - 09/2003
7	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 01/2005
7	3' Untranslated Regions (3' UTR)IBA 10/2013 - 04/2007
7	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2013 - 07/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2004
6	SaltsIBA 09/2011 - 04/2005
5	Nicotine FDA Link 01/2016 - 04/2002
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2013 - 01/2002
4	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 01/2022 - 05/2006
4	ViloxazineIBA 11/2021 - 01/2021
4	Indicators and Reagents (Reagents)IBA 01/2018 - 09/2002
4	AmphetaminesIBA 01/2018 - 03/2003
4	Illicit Drugs (Recreational Drugs)IBA 01/2017 - 02/2006
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 07/2013 - 08/2005
4	SmokeIBA 09/2012 - 04/2002
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2009 - 05/2007
4	EnzymesIBA 06/2007 - 04/2003
4	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 03/2007 - 03/2003
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 10/2006
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2022 - 09/2012
3	Glutamic Acid (Glutamate)FDA Link 01/2019 - 01/2013
3	4-aminospiroperidolIBA 10/2018 - 12/2007
3	Naltrexone (ReVia)FDA LinkGeneric 03/2018 - 10/2014
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 09/2013
3	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2017 - 04/2014
3	Guanfacine (Tenex)FDA LinkGeneric 02/2015 - 03/2010
3	BenzodiazepinesIBA 02/2015 - 02/2012
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2014 - 11/2008
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 06/2013 - 12/2011
3	Bupropion (Wellbutrin)FDA LinkGeneric 01/2013 - 01/2002
3	Monoamine Oxidase (MAO)IBA 10/2012 - 06/2007
3	AdderallIBA 07/2007 - 06/2002
3	Serotonin ReceptorsIBA 07/2006 - 01/2006
3	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2006 - 03/2002
2	Antimanic AgentsIBA 01/2022 - 08/2011
2	Opioid Analgesics (Opioids)IBA 01/2020 - 10/2014
2	Genetic Markers (Genetic Marker)IBA 01/2019 - 04/2008
2	Cocaine (Cocaine HCl)IBA 01/2019 - 06/2006
2	Narcotic Antagonists (Opioid Antagonists)IBA 03/2018 - 01/2018
2	Opiate AlkaloidsIBA 01/2018 - 06/2006
2	TOR Serine-Threonine KinasesIBA 01/2018 - 09/2012
2	Memantine (Namenda)FDA Link 01/2017 - 06/2016
2	Protons (Proton)IBA 04/2016 - 08/2005
2	SodiumIBA 04/2016 - 10/2013
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2016 - 10/2006
2	Messenger RNA (mRNA)IBA 01/2016 - 04/2005
2	RNA (Ribonucleic Acid)IBA 10/2015 - 12/2008
2	alpha-2 Adrenergic ReceptorsIBA 11/2013 - 03/2006
2	Sodium-Hydrogen ExchangersIBA 10/2013 - 01/2012
2	Adrenergic Agents (Adrenergic Drugs)IBA 07/2013 - 11/2006
2	Antidepressive Agents (Antidepressants)IBA 01/2013 - 02/2012
2	Polychlorinated Biphenyls (PCBs)IBA 12/2011 - 12/2008
2	Antipsychotic Agents (Antipsychotics)IBA 08/2011 - 05/2006
2	Neurofibromin 2 (Merlin)IBA 07/2010 - 10/2008

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 01/2021 - 07/2002
16	Therapeutics 01/2021 - 07/2002
4	Aftercare (After-Treatment) 01/2019 - 10/2005